Envirotainer, the global market leader in secure cold chain solutions for intercontinental shipments of pharmaceuticals, is launching the CryoSure platform today.
This -70oC solution, designed with today’s and tomorrow’s high demands in mind has unmatched performance, superior duration and is the most sustainable solution on the market.
The four models of the CryoSure platform; X1, X2, X5 and X11.
Whereas most of the temperature-controlled pharmaceutical shipment solutions have historically involved temperature ranges of 2–8°C and 15–25°C, many pharma products and biospecimen samples require below -70°C shipments.
With its superior duration of up to 3 weeks, heat resistance and unparalleled ease of use, CryoSure is the most reliable choice for -70°C cryogenic shipments, and for protecting patient safety.
“Envirotainer has been leading the way ever since the beginning of the temperature-controlled shipments and it is with great pride that we today announce the launch of CryoSure”, says Peter Gisel-Ekdahl, CEO at Envirotainer.
“We believe CryoSure fills a substantial gap in the cryogenic -70°C shipment market and significantly improves patient safety”.
“This new CryoSure technology takes pharma transportation to the next level by mitigating most if not all risks currently faced when shipping pharma products below -70°C”, says Mattias Almgren, CryoSure Platform Executive at Envirotainer.
“It is a game changer and is going to revolutionize this part of the market”.
“For many years, the strategy of Envirotainer has been to extend our offering through new innovative products and services and to expand into new segments”, says Fredrik Linnér, Chief Business Development Officer at Envirotainer.
“This technology fits perfectly into our circular business model and is going to be an important part of our offering going forward.
“The unique, premium quality, and completely reusable technology matches perfectly into Envirotainer’s global footprint”.